Chalkis Health Industry Co., Ltd announced a private placement of 44,642,857 shares at a price of CNY 2.24 for gross proceeds of not more than CNY 100,000,000 on August 22, 2022. The transaction will include participation from not more than 35 specific investors. The number of shares to be issued under the issuance shall not exceed 30% of the total capital of the company prior to the issuance.

The pricing benchmark date of the issuance shall be the first day of the issue period of the issuance. The issue price for this raising of supporting funds will not be less than 80% of the average trading price during the 20 trading days prior to the pricing base date. All the securities issued in the transaction must not be transferred within 6 months after issuance.

The transaction has been approved in the thirteenth session of the company's ninth directorate. The transaction is subject to approval by the shareholders of the company, State-owned Assets Supervision and Administration Commission of the Sixth Division of Xinjiang Production and Construction Corps and China Securities Regulatory Commission.